The stock market has been focused a lot on politics recently, but starting next week, earnings will once again be front and center, Jim Cramer told his Mad Money viewers Friday. Cramer said that President-elect Joe Biden's scheduled update Thursday on his economic recovery and stimulus plans is likely to move the market, but there will be plenty of individual stocks in the news as well.
Cramer's game plan for next week starts with the kickoff of the annual JP Morgan Chase (JPM) - Get Report healthcare conference on Monday, which will highlight many healthcare stocks that have great growth and don't need a strong economy to keep growing. He'll be listening to presentations from Bristol-Myers Squibb (BMY) - Get Report, Johnson & Johnson (JNJ) - Get Report, Moderna (MRNA) - Get Report, Regeneron (REGN) - Get Report and Emergent BioSolutions (EBS) - Get Report.
Next, on Tuesday, we'll most likely hear good things from Pfizer (PFE) - Get Report, CVS Health (CVS) - Get Report and AbbVie (ABBV) - Get Report. We will also see earnings from home builder KB Home (KBH) - Get Report. In tech, the annual CES show kicks off and Cramer will be watching the keynote from Advanced Micro Devices (AMD) - Get Report and Microsoft (MSFT) - Get Report on Wednesday.
Thursday will see earnings from Taiwan Semiconductor (TSMC) , which could move the entire semiconductor group. We will also hear from Delta Air Lines (DAL) - Get Report for an update on the travel sector.
Cramer and the AAP team are looking at everything from earnings and tariffs to the Federal Reserve. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts Plus.
Executive Decision: Micron Technology
In his first "Executive Decision" segment, Cramer spoke with Sanjay Mehrotra, president and CEO of Micron Technology (MU) - Get Report, the semiconductor maker with shares that fell 2.1% Friday after hitting new all-time highs earlier in the week.
Mehrotra said no matter what the technology trend, from artificial intelligence to 5G to the cloud, Micron's chips are a mission critical component. They continue to be leading the memory market in both DRAM and NAND flash chips.
Mehrotra noted that memory remains among the fastest growing segments to the semiconductor market. He also admitted that with demand so strong for memory of all kinds, some shortages in supply do exist. However, his company is ramping up new technologies to meet that demand.
Micron remains committed to its shareholder, Mehrotra said. The company has bought back $4.8 billion worth of its own shares over the past few years.
Cramer said he liked Micron at $30 a share and has been a fan ever since. He said shares could ultimately see $100.
Don’t miss Cramer’s best, every day, with fast, actionable strategies: StreetLightning.
On Real Money, Cramer keys in on the companies and CEOs he knows best. Get more of his insights with a free trial subscription to Real Money.
Oversupply Warrants Caution
This market may seem unstoppable, Cramer told viewers, but there is one thing that keeps him up at night... oversupply. He said last year there were a ton of red-hot IPOs and companies coming public via reverse mergers with specialty purpose acquisition companies, or SPACs. The problem? All of these deals have lockup periods that are now expiring, releasing millions of new shares into the market.
Cramer said he's been a big fan of online insurance company Lemonade (LMND) , but last month shares surged to $137 before suddenly plunging 14%. Why? Because the lockup period expired and sellers were finally able to sell. Cramer advised taking profits in this stock.
Finally, Cramer highlighted Snowflake (SNOW) - Get Report, the data and analytics software provider with amazing growth, but also a three-step lockup which completes in late March with a big lockup expiration. Cramer advised using extreme caution.
JP Morgan Healthcare Conference
In a special interview, Cramer welcomed back Lisa Gill, managing director at JP Morgan Chase, for a preview of the upcoming 39th annual JP Morgan Healthcare Conference.
Gill said that vaccines will be front and center at this year's conference, with presentations from Pfizer, Moderna, distribution giant McKesson (MCK) - Get Report, CVS Health and officials from Operation Warp Speed.
Beyond vaccines however, Gill was bullish on Teladoc (TDOC) - Get Report, the virtual healthcare provider that is now a $33 billion company. She said consumers are not going back after they've tried telemedicine and home is the safest place to be for healthcare services.
Gill was also bullish on CVS Health, both for the company's new CEO and also their transformation into a neighborhood healthcare destination, starting soon with the COVID vaccine.
Potential for Hydrogen
In his "No Huddle Offense" segment, Cramer reminisced about the early days of cell phones, when they were the size of a brick and weighed just as much, with the range of only a few square blocks. Back then, Cramer chose not to invest in this burgeoning technology, but there were true believers, he said, believers like Andy Marsh, now the CEO at Plug Power (PLUG) - Get Report.
March sees in clean hydrogen what he saw back then in cell phones: potential. Every new technology needs scale to bring down prices. Hydrogen now has the scale, coupled with growth in wind and solar, to make green hydrogen at the price of natural gas.
This story will take years to play out, Cramer admitted, but Marsh has already been at Plug Power since 2008. He's betting that, like cell phones, hydrogen will be the next big green energy revolution.
Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Friday evening:
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
At the time of publication, Cramer's Action Alerts PLUS had a position JPM, BMY, CVS, ABBV, AMD, MSFT.